Risk factors for early-onset Parkinson’s disease
5 affiliations
- 1Department of Neurosurgery, The Second Affiliated Hospital of Xi'an Jiaotong University
- 2Department of Cardiovascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University
- 3Department of Neurosurgery, 3201 Hospital
- 4School of Public Health, Xi'an Jiaotong University
- 5Xi’an Medical University
Abstract
Background: Prospective evidence on factors associated with early-onset Parkinson’s disease (EOPD) remains limited. We aimed to identify factors associated with incident EOPD and compare their associations with late-onset Parkinson’s disease (LOPD).
Methods: This prospective cohort study included 283,934 participants aged <60 years and free of Parkinson’s disease at baseline. Thirty-eight prespecified factors were evaluated using Cox regression with Benjamini–Hochberg false discovery rate correction, followed by an exploratory mutually adjusted analysis. Sex-stratified and EOPD–LOPD comparative analyses were conducted, and sensitivity analyses excluded EOPD events occurring within the first 2 or 5 years of follow-up.
Results: During 2,298,992 person-years of follow-up, 168 participants developed EOPD. After mutual adjustment, EOPD was associated with older age [hazard ratio (HR) per year, 1.15; 95% confidence interval (CI), 1.10–1.20], male sex (HR, 1.93; 95% CI, 1.41–2.64), a higher polygenic risk score (HR per unit, 1.53; 95% CI, 1.31–1.78), family history of Parkinson’s disease (HR, 4.03; 95% CI, 2.49–6.50), anxiety (HR, 2.48; 95% CI, 1.60–3.86), constipation (HR, 4.90; 95% CI, 3.31–7.25), and autoimmune disease burden (HR per category, 1.98; 95% CI, 1.32–2.96). Associations with handgrip strength, hypertension, and migraine were attenuated after mutual adjustment. The principal associations were broadly consistent after excluding EOPD events occurring within the first 2 and 5 years of follow-up. Interaction tests suggested stronger associations of family history, constipation, and autoimmune disease burden with EOPD than with LOPD.
Conclusion: EOPD showed a distinct profile of associated risk factors, particularly greater autoimmune disease burden and familial susceptibility. These findings support heterogeneity in Parkinson’s disease according to age at onset.
Related
- Global regional and national burden and trends of early-onset Parkinson’s disease from 1990 to 2021
- The Changing Global Epidemiology of Early-Onset Colorectal Cancer: Incidence Trends, Modifiable Risk Factors, and Future Burden Projections
- Umbrella Review and Evidence Map of Systematic Reviews and Meta-Analyses Risk Factors for Early-Onset Bipolar Disorder
- Global, Regional, and National Burden of Early-Onset Breast Cancer in Women, 1990-2021: GBD 2021 Analysis of Trends, Modifiable Risk Factors, and Health Inequalities.
- Genomic Landscape of Early-Onset and Familial Latin American Parkinson's Patients
BibTeX
@article{li2026risk,
title = {{Risk factors for early-onset Parkinson’s disease}},
author = {Lu-Yao Li and Zhe-Ming Yue and Bo-Wen Zhang and Fei-Yang Wang and Shou-Ping Gong and Yong-Xin Li},
journal = {Frontiers in Neurology},
year = {2026},
month = nov,
doi = {10.3389/fneur.2026.1938082},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1938082/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Risk factors for early-onset Parkinson’s disease
AU - Lu-Yao Li
AU - Zhe-Ming Yue
AU - Bo-Wen Zhang
AU - Fei-Yang Wang
AU - Shou-Ping Gong
AU - Yong-Xin Li
PY - 2026
DA - 2026/11/02
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1938082
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1938082/full
AB - Background: Prospective evidence on factors associated with early-onset Parkinson’s disease (EOPD) remains limited. We aimed to identify factors associated with incident EOPD and compare their associations with late-onset Parkinson’s disease (LOPD). Methods: This prospective cohort study included 283,934 participants aged <60 years and free of Parkinson’s disease at baseline. Thirty-eight prespecified factors were evaluated using Cox regression with Benjamini–Hochberg false discovery rate correction, followed by an exploratory mutually adjusted analysis. Sex-stratified and EOPD–LOPD comparative analyses were conducted, and sensitivity analyses excluded EOPD events occurring within the first 2 or 5 years of follow-up. Results: During 2,298,992 person-years of follow-up, 168 participants developed EOPD. After mutual adjustment, EOPD was associated with older age [hazard ratio (HR) per year, 1.15; 95% confidence interval (CI), 1.10–1.20], male sex (HR, 1.93; 95% CI, 1.41–2.64), a higher polygenic risk score (HR per unit, 1.53; 95% CI, 1.31–1.78), family history of Parkinson’s disease (HR, 4.03; 95% CI, 2.49–6.50), anxiety (HR, 2.48; 95% CI, 1.60–3.86), constipation (HR, 4.90; 95% CI, 3.31–7.25), and autoimmune disease burden (HR per category, 1.98; 95% CI, 1.32–2.96). Associations with handgrip strength, hypertension, and migraine were attenuated after mutual adjustment. The principal associations were broadly consistent after excluding EOPD events occurring within the first 2 and 5 years of follow-up. Interaction tests suggested stronger associations of family history, constipation, and autoimmune disease burden with EOPD than with LOPD. Conclusion: EOPD showed a distinct profile of associated risk factors, particularly greater autoimmune disease burden and familial susceptibility. These findings support heterogeneity in Parkinson’s disease according to age at onset.
SN - 1664-2295
ER -